Tracking Dynamics of Superspreading Through Contacts, Exposures, and Transmissions in Edge-Based Network Epidemics.

Publication date: Jun 25, 2026

Infectious disease superspreading caused by heterogeneity in contact behavior has been observed to be an important determinant of epidemic dynamics and size in both empirical and theoretical settings. However, it has also been observed that the importance of this type of superspreading changes throughout an epidemic, generally in a decreasing manner as infections cascade from individuals with many contacts to those with fewer contacts. We provide an exact mathematical formulation of this phenomenon in strongly-immunizing (SIR) epidemics on static contact networks. Building on the edge-based modeling framework, we construct three metrics to track how superspreading changes through the course of an epidemic, respectively measuring infected nodes’ contacts, exposures, and transmissions: (1) the mean degree of infected nodes, (2) the mean number of susceptible neighbors of infected nodes, and (3) the mean number of secondary cases that will be caused by newly infected nodes. We prove results about the behaviors of these metrics, highlighting the fact that their peak times all occur at less than half the time it takes for population-level infection prevalence to peak. This suggests that the importance of superspreading will be low when an epidemic is already near its peak, so contact-based control strategies are best employed as early in an outbreak as possible. We discuss implications for accurately measuring epidemiological parameters from incidence, mobility, contact tracing, and transmission data.

Open Access PDF

Concepts Keywords
Epidemics Disease modeling
Epidemiological Dispersion
Math Networks
Neighbors SARS-CoV-2
Peak Superspreading

Semantics

Type Source Name
disease MESH Infectious disease
pathway REACTOME Infectious disease
disease MESH infections
drug DRUGBANK Huperzine B
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Guanosine
drug DRUGBANK Trestolone
pathway REACTOME Reproduction
drug DRUGBANK Aspartame

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *